Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID Research in the Middle East and North Africa

The Middle East and North Africa region face many challenges, including instability and disparate economic performance, both of which have adverse effects on health and survival. Disruptions in health care, access to clean water, and sanitation are problems in the region.

In Bahrain, the World Health Organization (WHO) reports increasing incidence of gonorrhea, syphilis, and viral hepatitis. HIV/AIDS and hepatitis remain significant health problems in Iran and Qatar. In localized areas of Iraq, Iran, and Saudi Arabia, malaria remains endemic, according to WHO. MERS-CoV, a newly identified coronavirus, has spread to at least nine countries in the region. NIAID is significantly involved in research on the infectious diseases in​ the region, including MERS-CoV.

Countries With NIAID-Funded Activities (Fiscal Year 2015)

  • Israel
  • Morocco

 

View Larger Map

Highlights

NIAID-MENA Workshop on Emerging Viral Diseases, May 26-29, 2014, Doha, Qatar

Goals for this workshop included presenting scientific findings and research, discussing research challenges and opportunities in the region, sharing best practices related to viral research bio-safety and bio-security, and facilitating current and future research collaborations between investigators and institutions in MENA and the United States. Following the workshop, a competitive seed-grant program was launched, through which eligible scientists may apply for collaborative research awards.

Last Updated March 17, 2016